1. Home
  2. MCRB

MCRB

Seres Therapeutics Inc.

as 11-14-2024 10:34am EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 2010 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: N/A IPO Year: 2015
Target Price: $5.63 AVG Volume (30 days): 2.1M
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.17 EPS Growth: N/A
52 Week Low/High: $0.54 - $2.05 Next Earning Date: 11-13-2024
Revenue: $374,000 Revenue Growth: -99.71%
Revenue Growth (this year): -96.42% Revenue Growth (next year): 215.76%

MCRB Daily Stock ML Predictions

Stock Insider Trading Activity of Seres Therapeutics Inc. (MCRB)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Young Teresa L. MCRB See Remarks Oct 27 '24 Sell $0.69 2,983 $2,058.57 88,483
von Moltke Lisa MCRB See Remarks Oct 27 '24 Sell $0.69 4,334 $2,991.33 30,423
Shaff Eric D. MCRB CEO and President Oct 27 '24 Sell $0.69 8,748 $6,036.99 165,082
Henn Matthew R. MCRB See Remarks Oct 27 '24 Sell $0.69 3,984 $2,749.36 75,885

Share on Social Networks: